Similarly, the western blotting results demonstrated that the relative expression of TβRII was 0.203±0.142 in the NSCLC tissues and 0.882±0.334 in the control nonlesional lung tissues, revealing a statistically significant difference (P<0.05; Fig. 2). This evidence concerns the gene TGFBR2 and non-small cell lung carcinoma.